CSIMarket
 


Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 
 

ACRS's Operating Income Growth by Quarter and Year

Aclaris Therapeutics Inc 's Operating Income results by quarter and year




ACRS Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -22.89 -13.56 -1.07
III Quarter September -20.87 -20.30 -10.47 -22.86
II Quarter June -20.99 -18.01 -11.38 -49.79
I Quarter March -18.91 -28.53 -15.51 -37.34
FY   -60.77 -89.73 -50.92 -111.06



ACRS Operating Income third quarter 2022 Y/Y Growth Comment
Aclaris Therapeutics Inc in the third quarter 2022 recorded Operating Loss of $ -20.87 millions.

According to the results reported in the third quarter 2022, Aclaris Therapeutics Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Aclaris Therapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


ACRS Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Aclaris Therapeutics Inc 's third quarter 2022 Operating Income $ -20.87 millions ACRS's Income Statement
Aclaris Therapeutics Inc 's third quarter 2021 Operating Income $ -20.30 millions Quarterly ACRS's Income Statement
New: More ACRS's historic Operating Income Growth >>


ACRS Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Aclaris Therapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACRS's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Aclaris Therapeutics Inc in the III. Quarter 2022 admitted Operating Loss of $ -20.87 millions, it should be point out, that those numbers show improvement compare to the -20.99 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Aclaris Therapeutics Inc achieved highest sequential Operating Income growth. While Aclaris Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACRS's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Aclaris Therapeutics Inc in the III. Quarter 2022 revealed Operating Loss of $ -20.87 millions, some analyst mentioned, that those numbers show slight up side compare to the -20.99 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Aclaris Therapeutics Inc achieved highest sequential Operating Income growth. While Aclaris Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Aclaris Therapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -83.67 $ -83.09 $ -80.10 $ -89.72 $ -80.39
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Aclaris Therapeutics Inc ' has realized cumulative trailing twelve months Operating Loss of $ -84 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative Operating Loss is becoming larger from $ -83.09 millions in the twelve months ending a quarter before and $ -20.99 millions for the twelve months ending in the quarter a year ago.

Aclaris Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Aclaris Therapeutics Inc ' has realized cumulative trailing twelve months Operating Loss of $ -84 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative Operating Loss is becoming larger from $ -83.09 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -20.99 millions from the TTM period ending Sep 30 2021 Dominic King mentioned.

Aclaris Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ACRS's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ACRS's Competitors
Operating Income Growth for Aclaris Therapeutics Inc 's Suppliers
Operating Income Growth for ACRS's Customers

You may also want to know
ACRS's Annual Growth Rates ACRS's Profitability Ratios ACRS's Asset Turnover Ratio ACRS's Dividend Growth
ACRS's Roe ACRS's Valuation Ratios ACRS's Financial Strength Ratios ACRS's Dividend Payout Ratio
ACRS's Roa ACRS's Inventory Turnover Ratio ACRS's Growth Rates ACRS's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Syneos Health Inc 3.96%$ 3.958 millions
Edwards Lifesciences Corporation3.10%$ 3.100 millions
West Pharmaceutical Services Inc 2.65%$ 2.646 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

QIWI's Profile

Stock Price

QIWI's Financials

Business Description

Fundamentals

Charts & Quotes

QIWI's News

Suppliers

QIWI's Competitors

Customers & Markets

Economic Indicators

QIWI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071